Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
Public ClinicalTrials.gov record NCT06668493. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/2, Single-arm, Open-Label Trial to Evaluate the Safety and Efficacy of Nadofaragene Firadenovec Instilled to the Renal Pelvis in Adult Subjects With Low-grade Upper Tract Urothelial Carcinoma (LG-UTUC)
Study identification
- NCT ID
- NCT06668493
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Ferring Pharmaceuticals
- Industry
- Enrollment
- 20 participants
Conditions and interventions
Conditions
Interventions
- Nadofaragene Firadenovec Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 11, 2025
- Primary completion
- Nov 29, 2029
- Completion
- Nov 29, 2029
- Last update posted
- May 7, 2026
2025 – 2029
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic - Scottsdale Arizona | Scottsdale | Arizona | 85054 | Recruiting |
| Providence Saint John's Cancer Institute | Santa Monica | California | 90404 | Recruiting |
| Mayo Clinic | Jacksonville | Florida | 32224 | Recruiting |
| Indiana University | Indianapolis | Indiana | 46202 | Recruiting |
| Mayo Clinic - Rochester Minnesota | Rochester | Minnesota | 55905 | Recruiting |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | Recruiting |
| University of Pennsylvania - Perelman Center for Advanced Medicine - Penn Urology | Philadelphia | Pennsylvania | 19104 | Recruiting |
| Baylor College of Medicine (Houston) | Houston | Texas | 77030 | Recruiting |
| MD Anderson Cancer Center - Genitourinary (GU) Cancer Center | Houston | Texas | 77030 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06668493, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2026 · Synced May 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06668493 live on ClinicalTrials.gov.